Projects

Browse through our collection of selected research projects and discover the diversity of European cooperation in Lower Saxony!

AI-based solutions for monitoring biodiversity in agriculture

The aim of the BioMonitor4CAP project is to develop, implement and evaluate systems for measuring biodiversity in agriculture. In particular, the aim is to record biodiversity characteristics and their spatial and temporal changes. The findings should support the implementation of strategies in European agricultural landscapes to improve biodiversity.

EU project aims to establish optimal therapy for blood cancer

Acute myeloid leukaemia (AML) and chronic lymphocytic leukaemia (CLL) are among the most common forms of blood cancer in adults. Depending on the stage of the disease, patients receive chemotherapy, immunotherapy or a stem cell transplant. The so-called measurable residual disease (MRD) can be used to determine whether the leukaemia is responding very well to the therapy early on in the course of treatment.

Combating climate change with SpongeScapes

Too hot, too dry, too wet: Europe’s landscapes have already been visibly affected by climate change. In recent years, floods and droughts have caused damage amounting to billions of Euros. The SpongeScapes project was launched in October 2023 and aims to counteract the consequences of climate change by establishing sponge landscapes. The European Commission is funding the research project with a total of 2.6 million euros under the Horizon Europe programme.

From the lab to the market: enabling bone repair

When bones fail to heal – for example after an accident or cancer treatment – bone defects remain, placing a burden on patients as well as society and the economy. “Worldwide, more than four million operations per year require bone grafts or substitutes. At the same time, current treatment options are limited.

More impact against cancer

Natural killer cells (NK cells) are part of the first line of defense of our immune system. They eliminate virus-infested cells and tumor cells. This makes NK cells interesting helpers in cancer therapy. Professor Dr. Dr. Axel Schambach, head of the Institute of Experimental Haematology at the Hannover Medical School (MHH), wants to genetically modify the immune cells in such a way that they detect and destroy the tumor cells even more reliably.